Thus taken together with our results of prostatic tissues and cell lines, these findings strongly suggest that DNA hypomethylation of the CYP1A1 enhancer is a frequent event in prostate cancer and involved in the induction of CYP1A1 expression. Here, CYP1A1 is linked to prostate carcinoma.